Financial reports
ARS
2023 FY
Annual report to shareholders
10 Apr 24
10-K
2023 FY
Annual report
5 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
2 May 23
ARS
2022 FY
Annual report to shareholders
14 Apr 23
10-K
2022 FY
Annual report
7 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
3 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
12 Apr 24
8-K
Rigel Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
5 Mar 24
8-K
Entry into a Material Definitive Agreement
22 Feb 24
8-K
Rigel Pharmaceuticals Provides Business Update
8 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Nov 23
8-K
Rigel Reports Third Quarter 2023 Financial Results and Provides Business Update
7 Nov 23
8-K
Rigel Reports Second Quarter 2023 Financial Results and Provides Business Update
1 Aug 23
8-K
Departure of Directors or Certain Officers
30 May 23
8-K
Rigel Reports First Quarter 2023 Financial Results and Provides Business Update
2 May 23
8-K
Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
7 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
1 Aug 23
S-8
Registration of securities for employees
7 Mar 23
S-8
Registration of securities for employees
3 Aug 22
S-8
Registration of securities for employees
1 Mar 22
POS AM
Prospectus update (post-effective amendment)
1 Mar 22
POSASR
Automatic shelf registration (post-effective amendment)
1 Mar 22
S-3ASR
Automatic shelf registration
3 Aug 21
S-8
Registration of securities for employees
21 Jun 21
S-8
Registration of securities for employees
4 Aug 20
424B5
Prospectus supplement for primary offering
4 Aug 20
Proxies
DEFA14A
Additional proxy soliciting materials
10 Apr 24
DEF 14A
Definitive proxy
10 Apr 24
PRE 14A
Preliminary proxy
29 Mar 24
DEFR14A
Revised proxy
15 May 23
DEFA14A
Additional proxy soliciting materials
14 Apr 23
DEF 14A
Definitive proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
5 Apr 22
DEF 14A
Definitive proxy
5 Apr 22
DEF 14A
Definitive proxy
6 Apr 21
DEFA14A
Additional proxy soliciting materials
1 May 20
Other
EFFECT
Notice of effectiveness
4 May 22
CT ORDER
Confidential treatment order
24 Apr 20
CT ORDER
Confidential treatment order
24 Apr 20
SEC STAFF
SEC staff action: Order
18 Feb 20
SEC STAFF
SEC staff action: Order
5 Feb 20
CT ORDER
Confidential treatment order
16 Jan 20
CT ORDER
Confidential treatment order
16 Jan 20
CT ORDER
Confidential treatment order
16 Jan 20
CT ORDER
Confidential treatment order
20 Mar 19
CORRESP
Correspondence with SEC
2 Apr 18
Ownership